{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:58:15Z","timestamp":1784300295811,"version":"3.55.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.critrevonc.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T11:14:10Z","timestamp":1395573250000},"page":"130-141","source":"Crossref","is-referenced-by-count":40,"title":["Follow-up of patients with early breast cancer: Is it time to rewrite the story?"],"prefix":"10.1016","volume":"91","author":[{"given":"Fabio","family":"Puglisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmauro","family":"Numico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Monetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.critrevonc.2014.03.001_bib0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJM200010123431506","article-title":"Primary care for survivors of breast cancer","volume":"343","author":"Burstein","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0015","first-page":"CD001768","article-title":"Follow-up strategies for women treated for early breast cancer","volume":"25","author":"Rojas","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3109\/0284186X.2013.774461","article-title":"Quality of life in long-term breast cancer survivors \u2013 a 10-year longitudinal population-based study","volume":"52","author":"Koch","year":"2013","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1023\/A:1011624829512","article-title":"Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study","volume":"12","author":"Jacobs","year":"2001","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.critrevonc.2014.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jama.1994.03510440047031","article-title":"Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial","volume":"271","author":"The GIVIO Investigators","year":"1994","journal-title":"JAMA"},{"issue":"(20) May","key":"10.1016\/j.critrevonc.2014.03.001_bib0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.271.20.1593","article-title":"Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial, National Research Council Project on Breast Cancer follow-up","volume":"271","author":"Rosselli Del Turco","year":"1994","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.critrevonc.2014.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jama.281.17.1586","article-title":"Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up","volume":"281","author":"Palli","year":"1999","journal-title":"JAMA"},{"issue":"7075","key":"10.1016\/j.critrevonc.2014.03.001_bib0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bmj.314.7075.174","article-title":"Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study","volume":"314","author":"Gulliford","year":"1997","journal-title":"BMJ"},{"issue":"7058","key":"10.1016\/j.critrevonc.2014.03.001_bib0050","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.313.7058.665","article-title":"Routine follow up of breast cancer in primary care: randomized trial","volume":"313","author":"Grunfeld","year":"1996","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1200\/JCO.2005.03.2235","article-title":"Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care","volume":"24","author":"Grunfeld","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.critrevonc.2014.03.001_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Khatcheressian","year":"2013","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.critrevonc.2014.03.001_bib0065","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1056\/NEJMcp067260","article-title":"Clinical practice. Follow-up of patients with early breast cancer","volume":"356","author":"Hayes","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0070","unstructured":"NCCN Guidelines: Breast Cancer Version 3. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf; 2013; [accessed 27.01.14]"},{"issue":"Suppl. 6","key":"10.1016\/j.critrevonc.2014.03.001_bib0075","doi-asserted-by":"crossref","first-page":"vi12","DOI":"10.1093\/annonc\/mdr371","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Aebi","year":"2011","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.2000.18.8.1718","article-title":"Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center","volume":"18","author":"Mille","year":"2000","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.critrevonc.2014.03.001_bib0085","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s11606-011-1808-4","article-title":"Differences between primary care physicians\u2019 and oncologists\u2019 knowledge, attitudes and practices regarding the care of cancer survivors","volume":"26","author":"Potosky","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"14","key":"10.1016\/j.critrevonc.2014.03.001_bib0090","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2012.42.8375","article-title":"American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology","volume":"30","author":"Schnipper","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2014.03.001_bib0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JOP.200009","article-title":"Population-based longitudinal study of follow-up care for breast cancer survivors","volume":"6","author":"Grunfeld","year":"2010","journal-title":"J Oncol Pract"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0100","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1200\/JCO.2006.08.6876","article-title":"Surveillance testing among survivors of early-stage breast cancer","volume":"25","author":"Keating","year":"2007","journal-title":"J Clin Oncol"},{"issue":"15 Suppl.","key":"10.1016\/j.critrevonc.2014.03.001_bib0105","first-page":"e19592","article-title":"How are cared surviving cancer patients? Results of an Italian national survey to medical oncologists (MO) about clinical and organizational features of follow-up (FU)","volume":"30","author":"Numico","year":"2012","journal-title":"J Clin Oncol (Proc ASCO Annu Meet)"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2011.36.9264","article-title":"Breast cancer survivors\u2019 perceptions of survivorship care options","volume":"30","author":"Mayer","year":"2012","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.critrevonc.2014.03.001_bib0115","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1200\/JCO.2006.06.5284","article-title":"Failing to plan is planning to fail: improving the quality of care with survivorship care plans","volume":"24","author":"Earle","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0120","first-page":"980","article-title":"Cancer screening practices of cancer survivors: population-based, longitudinal study","volume":"58","author":"Grunfeld","year":"2012","journal-title":"Can Fam Physician"},{"issue":"(17) June","key":"10.1016\/j.critrevonc.2014.03.001_bib0125","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1200\/JCO.2010.32.3550","article-title":"Breast cancer adjuvant therapy: time to consider its time-dependent effects","volume":"29","author":"Jatoi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.critrevonc.2014.03.001_bib0130","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/annonc\/mds586","article-title":"Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement","volume":"23","author":"Guiu","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3322\/caac.20029","article-title":"New molecular classifications of breast cancer","volume":"59","author":"Cianfrocca","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0140","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"(25) September","key":"10.1016\/j.critrevonc.2014.03.001_bib0145","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1200\/JCO.2012.46.1574","article-title":"Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX","volume":"31","author":"Metzger-Filho","year":"2013","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.critrevonc.2014.03.001_bib0150","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1200\/JCO.2010.32.3550","article-title":"Breast cancer adjuvant therapy: time to consider its time-dependent effects","volume":"29","author":"Jatoi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0155","series-title":"SEER cancer statistics review, 1975\u20132001","author":"Ries","year":"2004"},{"issue":"(8) August","key":"10.1016\/j.critrevonc.2014.03.001_bib0160","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/annonc\/mdg347","article-title":"Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\/82) comparing tamoxifen with observation","volume":"14","author":"Waeber","year":"2003","journal-title":"Ann Oncol"},{"issue":"24 Suppl.","key":"10.1016\/j.critrevonc.2014.03.001_bib0165","first-page":"96s","article-title":"Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: the CALOR trial (chemotherapy as adjuvant for locally recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02)","volume":"72","author":"Aebi","year":"2012","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0170","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ejso.2006.06.001","article-title":"Patterns of breast cancer relapse","volume":"32","author":"Elder","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clbc.2013.04.002","article-title":"Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy","volume":"13","author":"Saigal","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"(2) April\u2013June","key":"10.1016\/j.critrevonc.2014.03.001_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0973-1482.34683","article-title":"Patterns of relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery and radiotherapy","volume":"3","author":"Yadav","year":"2007","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis","volume":"114","author":"Lu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1005897227030","article-title":"Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions","volume":"45","author":"Stomper","year":"1997","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19920715)70:2<493::AID-CNCR2820700219>3.0.CO;2-3","article-title":"Detection of local recurrence after conservative therapy for breast carcinoma","volume":"70","author":"Dershaw","year":"1992","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1148\/radiology.183.1.1312733","article-title":"Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection","volume":"183","author":"Orel","year":"1992","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0205","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1365-2168.1999.01163.x","article-title":"Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence","volume":"86","author":"Winehouse","year":"1999","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1148\/radiology.200.3.8756908","article-title":"Contrast-enhanced CT: value for diagnosing local breast cancer recurrence after conservative treatment","volume":"200","author":"Hagay","year":"1996","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1015868406986","article-title":"Magnetic resonance imaging in breast cancer recurrence","volume":"73","author":"Belli","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1148\/radiology.220.1.r01jl3113","article-title":"MR imaging of the breast for the detection, diagnosis, and staging of breast cancer","volume":"220","author":"Orel","year":"2001","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.critrevonc.2014.03.001_bib0225","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00432-009-0746-6","article-title":"FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis","volume":"136","author":"Pan","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N Engl J Med"},{"issue":"9473","key":"10.1016\/j.critrevonc.2014.03.001_bib0235","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0240","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/cncr.20971","article-title":"Screening women at high risk for breast cancer with mammography and magnetic resonance imaging","volume":"103","author":"Lehman","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1075-122X.2005.00121.x","article-title":"Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging","volume":"11","author":"Menell","year":"2005","journal-title":"Breast J"},{"issue":"11","key":"10.1016\/j.critrevonc.2014.03.001_bib0250","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/caac.20028","article-title":"Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?","volume":"59","author":"Houssami","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"(8) August","key":"10.1016\/j.critrevonc.2014.03.001_bib0260","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/bjs.1800840831","article-title":"Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer","volume":"84","author":"Mumtaz","year":"1997","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s003300050463","article-title":"MRI of the breast: state of the art","volume":"8","author":"Friedrich","year":"1998","journal-title":"Eur Radiol"},{"issue":"3 C","key":"10.1016\/j.critrevonc.2014.03.001_bib0270","first-page":"2159","article-title":"Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer","volume":"18","author":"Kr\u00e4mer","year":"1998","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0275","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00004728-199709000-00024","article-title":"Value of MR mammography in the detection and exclusion of recurrent breast carcinoma","volume":"21","author":"Rieber","year":"1997","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1148\/radiology.188.2.8327700","article-title":"Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients","volume":"188","author":"Gilles","year":"1993","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0285","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiology.187.3.8497625","article-title":"Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging","volume":"187","author":"Dao","year":"1993","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiology.210.3.r99mr43807","article-title":"Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience","volume":"210","author":"Hathaway","year":"1999","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10549-011-1773-y","article-title":"Use of high technology imaging for surveillance of early stage breast cancer","volume":"131","author":"Panageas","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0300","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2013.52.7515","article-title":"An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence","volume":"32","author":"Houssami","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0305","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2002.20.3.620","article-title":"Can we cure limited metastatic breast cancer?","volume":"20","author":"Hortobagyi","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0310","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12282-012-0347-0","article-title":"Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review","volume":"19","author":"Kobayashi","year":"2012","journal-title":"Breast Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2014.03.001_bib0315","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/0959-8049(96)00189-X","article-title":"Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study","volume":"32A","author":"Tomiak","year":"1996","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0320","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.1996.14.8.2197","article-title":"Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer","volume":"14","author":"Greenberg","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0325","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.8-3-241","article-title":"A role for curative surgery in the treatment of selected patients with metastatic breast cancer","volume":"8","author":"Singletary","year":"2003","journal-title":"Oncologist"},{"issue":"(10) November","key":"10.1016\/j.critrevonc.2014.03.001_bib0330","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/1097-0142(19941115)74:10<2791::AID-CNCR2820741008>3.0.CO;2-Q","article-title":"Surgery for pulmonary metastases. Who are the 10-year survivors?","volume":"74","author":"Girard","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0335","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0003-4975(10)64189-6","article-title":"A perspective on chest wall resection in patients with breast cancer","volume":"38","author":"McKenna","year":"1984","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.critrevonc.2014.03.001_bib0340","first-page":"468","article-title":"Surgical management of isolated systemic metastases","volume":"7","author":"Temple","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0345","first-page":"7","article-title":"Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED): The M.D. Anderson experience","volume":"7","author":"Holmes","year":"1994","journal-title":"Breast Dis"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0350","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clbc.2012.11.001","article-title":"Incidence patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment","volume":"13","author":"Berman","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2014.03.001_bib0355","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0360","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2008.19.9844","article-title":"Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review","volume":"28","author":"Dawood","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study","volume":"14","author":"Swain","year":"2013","journal-title":"Lancet Oncol"},{"issue":"50","key":"10.1016\/j.critrevonc.2014.03.001_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14500","article-title":"A systematic review of positron emission tomography (PET) and positron emission tomography\/computed tomography (PET\/CT) for the diagnosis of breast cancer recurrence","volume":"14","author":"Pennant","year":"2010","journal-title":"Health Technol Assess"},{"issue":"11","key":"10.1016\/j.critrevonc.2014.03.001_bib0380","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/cncr.22292","article-title":"The role of FDG-PET\/CT in suspected recurrence of breast cancer","volume":"107","author":"Radan","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0385","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10549-006-9218-8","article-title":"Computed tomography in suspected local breast cancer recurrence","volume":"100","author":"Ternier","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.critrevonc.2014.03.001_bib0390","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.RLI.0000063983.86229.f2","article-title":"F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging","volume":"38","author":"Gallowitsch","year":"2003","journal-title":"Invest Radiol"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0395","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/RLU.0b013e31805375e0","article-title":"Impact of PET\/CT in comparison with same day contrast enhanced CT in breast cancer management","volume":"32","author":"Piperkova","year":"2007","journal-title":"Clin Nucl Med"},{"issue":"14","key":"10.1016\/j.critrevonc.2014.03.001_bib0400","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2014.03.001_bib0405","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group","volume":"16","author":"Hortobagyi","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0410","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0959-8049(97)10128-9","article-title":"Bone metastases\u2014the clinical problem","volume":"34","author":"Rubens","year":"1998","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0415","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11864-013-0265-1","article-title":"How do I follow patients with early breast cancer after completing adjuvant therapy","volume":"15","author":"Matro","year":"2013","journal-title":"Curr Treat Options Oncol"},{"issue":"664","key":"10.1016\/j.critrevonc.2014.03.001_bib0420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1259\/0007-1285-56-664-233","article-title":"The role of computed tomography in the detection of bone metastases in breast cancer patients","volume":"56","author":"Muindi","year":"1983","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0425","first-page":"158","article-title":"Current imaging in spinal metastatic disease","volume":"18","author":"Kamholtz","year":"1991","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2014.03.001_bib0430","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdr397","article-title":"Imaging bone metastases in breast cancer: evidence on comparative test accuracy","volume":"23","author":"Houssami","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2014.03.001_bib0435","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02307064","article-title":"Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money","volume":"2","author":"Yeh","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0440","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00256-010-0963-8","article-title":"A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer","volume":"40","author":"Liu","year":"2011","journal-title":"Skeletal Radiol"},{"issue":"2C","key":"10.1016\/j.critrevonc.2014.03.001_bib0445","first-page":"1859","article-title":"The value of positron emission tomography in the follow-up for breast cancer","volume":"23","author":"Siggelkow","year":"2003","journal-title":"Anticancer Res"},{"issue":"415 Suppl.","key":"10.1016\/j.critrevonc.2014.03.001_bib0450","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/01.blo.0000093051.96273.7c","article-title":"Diagnosis of occult bone metastases: positron emission tomography","author":"Peterson","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0455","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12149-011-0488-9","article-title":"Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET\/CT? Results from small population with previous breast cancer","volume":"25","author":"Evangelista","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0460","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/RLU.0b013e31824850b0","article-title":"Tumor marker-guided PET in breast cancer patients-a recipe for a perfect wedding: a systematic literature review and meta-analysis","volume":"37","author":"Evangelista","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0465","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.surg.2013.04.004","article-title":"Quality of post-treatment surveillance of early stage breast cancer in Texas","volume":"154","author":"Parmar","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0470","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdq343","article-title":"Positron emission tomography\/computed tomography in the management of recurrent\/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital","volume":"22","author":"Constantinidou","year":"2011","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.critrevonc.2014.03.001_bib0475","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00006231-200209000-00009","article-title":"Comparison of fluorodeoxyglucose positron emission tomography and \u201cconventional diagnostic procedures\u201d for the detection of distant metastases in breast cancer patients","volume":"23","author":"Dose","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0480","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.RLI.0000063983.86229.f2","article-title":"F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging","volume":"38","author":"Gallowitsch","year":"2003","journal-title":"Invest Radiol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0485","first-page":"1859","article-title":"The value of positron emission tomography in the follow-up for breast cancer","volume":"23","author":"Siggelkow","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0490","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2214\/ajr.183.2.1830479","article-title":"Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer","volume":"183","author":"Eubank","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0495","first-page":"61","article-title":"A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients","volume":"50","author":"Santiago","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.critrevonc.2014.03.001_bib0500","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jjco\/hyf052","article-title":"Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report","volume":"32","author":"Liu","year":"2002","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0505","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0510","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-004-3291-7","article-title":"A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases","volume":"90","author":"Isasi","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.critrevonc.2014.03.001_bib0515","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02985050","article-title":"Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer","volume":"19","author":"Abe","year":"2005","journal-title":"Ann Nucl Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0520","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00006231-200108000-00005","article-title":"Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy","volume":"22","author":"Ohta","year":"2001","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0525","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejrad.2008.10.031","article-title":"Integrated contrast-enhanced diagnostic whole-body PET\/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer","volume":"73","author":"Dirisamer","year":"2010","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.critrevonc.2014.03.001_bib0530","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.rct.0000284394.83696.42","article-title":"F-18-fluoro-2-deoxyglucose positron emission tomography\/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers","volume":"31","author":"Haug","year":"2007","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0535","first-page":"325","article-title":"Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients","volume":"43","author":"Vranjesevic","year":"2002","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0540","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00268-005-0207-6","article-title":"The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer","volume":"30","author":"Wolfort","year":"2006","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0545","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2967\/jnmt.108.059584","article-title":"Economic evaluation of PET and PET\/CT in oncology: evidence and methodologic approaches","volume":"38","author":"Buck","year":"2010","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0550","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2511081300","article-title":"Whole-body PET\/CT scanning: estimation of radiation dose and cancer risk","volume":"251","author":"Huang","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0555","first-page":"93","article-title":"Cancer screening with whole-body PET\/CT for healthy asymptomatic people in Japan: re-evaluation of its test validity and radiation exposure","volume":"8","author":"Ghotbi","year":"2007","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"10.1016\/j.critrevonc.2014.03.001_bib0560","first-page":"623","article-title":"Clinical applications of serum tumor markers","volume":"115","author":"Bates","year":"1991","journal-title":"Adv Intern Med"},{"issue":"12","key":"10.1016\/j.critrevonc.2014.03.001_bib0565","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","article-title":"BRCA mutations in the management of breast cancer: the state of the art","volume":"7","author":"Narod","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0570","article-title":"p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors","author":"Yamamoto","year":"2013","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.critrevonc.2014.03.001_bib0575","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1200\/JCO.2002.08.135","article-title":"Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance","volume":"20","author":"Stathopoulou","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0580","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr2897","article-title":"Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse","volume":"13","author":"Saloustros","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0585","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10549-008-0191-2","article-title":"Validation of 70-gene prognosis signature in node-negative breast cancer","volume":"117","author":"Bueno-de-Mesquita","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2666-z","article-title":"The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis","volume":"141","author":"Carlson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"22","key":"10.1016\/j.critrevonc.2014.03.001_bib0595","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1200\/JCO.2012.46.1558","article-title":"Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy","volume":"31","author":"Dowsett","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2014.03.001_bib0600","doi-asserted-by":"crossref","first-page":"e58483","DOI":"10.1371\/journal.pone.0058483","article-title":"Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer","volume":"8","author":"Varga","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0605","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-013-2640-9","article-title":"Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients","volume":"140","author":"Naoi","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.critrevonc.2014.03.001_bib0610","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0615","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1373\/clinchem.2010.150730","article-title":"Intracellular and extracellular microRNAs in breast cancer","volume":"57","author":"Corcoran","year":"2011","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.critrevonc.2014.03.001_bib0620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1373\/clinchem.2013.210542","article-title":"Prognostic significance of metastasis-related MicroRNAs in early breast cancer patients with a long follow-up","volume":"60","author":"Markou","year":"2014","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.critrevonc.2014.03.001_bib0625","doi-asserted-by":"crossref","first-page":"e76729","DOI":"10.1371\/journal.pone.0076729","article-title":"Plasma microRNA panel for minimally invasive detection of breast cancer","volume":"8","author":"Cuk","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2014.03.001_bib0630","unstructured":"Linee guida AIOM -Associazione Italiana di Oncologia Medica- http:\/\/www.aiom.it\/area+pubblica\/area+medica\/prodotti+scientifici\/linee+guida\/1,333,1"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281400050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281400050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:07:57Z","timestamp":1597601277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084281400050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S104084281400050X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2014.03.001","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}